Prestige Consumer Healthcare Inc.
PBH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $274,114 | $249,530 | $296,755 | $290,317 |
| % Growth | 9.9% | -15.9% | 2.2% | – |
| Cost of Goods Sold | $120,043 | $114,381 | $121,044 | $129,268 |
| Gross Profit | $154,071 | $135,149 | $175,711 | $161,049 |
| % Margin | 56.2% | 54.2% | 59.2% | 55.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $28,037 | $28,456 | $27,050 | $26,182 |
| SG&A Expenses | $66,738 | $63,393 | $64,054 | $64,127 |
| Sales & Mktg Exp. | $38,701 | $34,937 | $37,004 | $37,945 |
| Other Operating Expenses | $7,663 | $0 | $23,229 | $4,960 |
| Operating Expenses | $74,401 | $63,393 | $87,283 | $69,087 |
| Operating Income | $79,670 | $71,756 | $88,428 | $91,962 |
| % Margin | 29.1% | 28.8% | 29.8% | 31.7% |
| Other Income/Exp. Net | -$10,537 | -$9,979 | -$14,469 | -$11,808 |
| Pre-Tax Income | $69,133 | $61,777 | $73,959 | $80,154 |
| Tax Expense | $26,922 | $14,311 | $23,831 | $19,122 |
| Net Income | $42,211 | $47,466 | $50,128 | $61,032 |
| % Margin | 15.4% | 19% | 16.9% | 21% |
| EPS | 0.86 | 0.96 | 1.01 | 1.23 |
| % Growth | -10.4% | -5% | -17.9% | – |
| EPS Diluted | 0.86 | 0.95 | 1 | 1.22 |
| Weighted Avg Shares Out | 49,025 | 49,475 | 49,697 | 49,597 |
| Weighted Avg Shares Out Dil | 49,264 | 49,833 | 50,080 | 49,993 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $10,036 | $10,203 | $10,759 | $11,455 |
| Depreciation & Amortization | $7,663 | $7,666 | $7,252 | $6,868 |
| EBITDA | $86,832 | $79,646 | $91,970 | $98,477 |
| % Margin | 31.7% | 31.9% | 31% | 33.9% |